Kingsview Wealth Management’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,000
Closed -$227K 892
2021
Q4
$227K Buy
+2,000
New +$243K 0.01% 825

Other funds holding CURE

Kingsview Wealth Management's CURE Position: Q1 2022 in Review

Kingsview Wealth Management sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q1 2022, closing a stake of 80 shares — an estimated $12K sold.

Kingsview Wealth Management first reported a position in CURE in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 22 funds tracked by Wall St. Rank hold CURE as of Q1 2022.

  • Kingsview Wealth Management reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q1 2022 after selling out during the quarter.
  • Kingsview Wealth Management sold 80 Direxion Daily Healthcare Bull 3X ETF shares in Q1 2022, an estimated $12K.
  • Kingsview Wealth Management first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q4 2021 and held it in 1 quarter.
  • Kingsview Wealth Management's Direxion Daily Healthcare Bull 3X ETF position peaked at $12K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2022.

Based on Kingsview Wealth Management's 13F filing for Q1 2022, filed 8 Feb 2024.